Studies related to Symptoms of Multiple Sclerosis and Modafinil

Impact Of Armodafinil On Cognition In Multiple Sclerosis: A Randomized, Double-blind Crossover Pilot Study

Effect Decrease
Trial Design Double blind
Trial Length 24 hours
Number of Subjects 14
Sex Both Genders
Age Range 65+
Notes for this study:
Acute supplementation of 250mg armodafinil to elderly persons with multiple sclerosis is able to improve memory performance on a list learning task yet appears ineffective in improving fatigue, processing speed, and executive functioning.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.